These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6090179)

  • 21. Increase in rat cortical [3H]naloxone binding site density after chronic administration of antidepressant agents.
    Antkiewicz-Michaluk L; Rokosz-Pelc A; Vetulani J
    Eur J Pharmacol; 1984 Jun; 102(1):179-81. PubMed ID: 6090155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A highly selective ligand for brain delta opiate receptors, a cyclopropyl(E)Phe(4)-enkephalin analog, suppresses mu receptor-mediated thermal analgesia by morphine.
    Shimohigashi Y; Takano Y; Kamiya H; Costa T; Herz A; Stammer CH
    FEBS Lett; 1988 Jun; 233(2):289-93. PubMed ID: 2838332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Opioid activity of peptides and wound healing of the skin].
    Vinogradov VA; Spevak SE; Iarygin KN; Korobov NV; Solov'eva AI
    Biull Eksp Biol Med; 1987 Jul; 104(7):89-91. PubMed ID: 3040149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential coupling of mu-competitive and mu-noncompetitive delta opiate receptors to guanine nucleotide binding proteins in rat brain membranes.
    Bowen WD; Rodrigues PA; Wanzor TE; Jacobson AE; Rice KC
    Biochem Pharmacol; 1988 Feb; 37(3):467-72. PubMed ID: 2827687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes.
    Cruciani RA; Lutz RA; Munson PJ; Rodbard D
    J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Melphalan potently substitutes the N-terminal Tyr of D-Ala2-Leu5-enkephalin methyl ester.
    Szücs M; Di Gleria K; Medzihradszky K
    FEBS Lett; 1985 Jan; 179(1):87-90. PubMed ID: 2981183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of kappa opioid agonists in the rat hippocampal slice.
    Brookes A; Bradley PB
    Neuropeptides; 1984 Dec; 5(1-3):261-4. PubMed ID: 6099507
    [No Abstract]   [Full Text] [Related]  

  • 28. Opioid receptor subtypes involved in the central inhibition of urinary bladder motility.
    Dray A; Metsch R
    Eur J Pharmacol; 1984 Sep; 104(1-2):47-53. PubMed ID: 6094211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel phencyclidine analog interacts selectively with mu opioid receptors.
    Itzhak Y; Simon EJ
    J Pharmacol Exp Ther; 1984 Aug; 230(2):383-6. PubMed ID: 6086884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioid receptor-mediated inhibition of omega-conotoxin GVIA-sensitive calcium channel currents in rat intracardiac neurons.
    Adams DJ; Trequattrini C
    J Neurophysiol; 1998 Feb; 79(2):753-62. PubMed ID: 9463438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the antinociceptive action of mu and delta opioid receptor ligands in the periaqueductal gray matter, medial and paramedial ventral medulla in the rat as studied by the microinjection technique.
    Jensen TS; Yaksh TL
    Brain Res; 1986 May; 372(2):301-12. PubMed ID: 2871901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative involvement of receptor subtypes in opioid-induced inhibition of gastrointestinal transit in mice.
    Ward SJ; Takemori AE
    J Pharmacol Exp Ther; 1983 Feb; 224(2):359-63. PubMed ID: 6296358
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of di- and trivalent metal ions on the complexing of D-ala2, D-leu5-enkephalin with opiate receptors of brain membrane preparations].
    Zaĭtsev SV; Porodenko NV; Varfolomeev SD
    Dokl Akad Nauk SSSR; 1984; 277(5):1260-3. PubMed ID: 6094131
    [No Abstract]   [Full Text] [Related]  

  • 34. [Stability of opiate receptors of wet and lyophilized preparations of rat brain membranes].
    Zaĭtsev SV; Kurochkin IN; Sergeeva MG; Varfolomeev SD
    Biokhimiia; 1984 Jul; 49(7):1127-33. PubMed ID: 6089917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional variations in binding capacities at mu-, delta- and kappa-opioid sites in membrane suspensions from rabbit brain.
    Petrillo P; La Regina A; Sbacchi M; Tavani A; Robson LE; Kosterlitz HW
    Eur J Pharmacol; 1989 Jul; 166(2):213-7. PubMed ID: 2551699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites.
    Nishimura SL; Recht LD; Pasternak GW
    Mol Pharmacol; 1984 Jan; 25(1):29-37. PubMed ID: 6323950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opiate and opioid peptide binding in rat goldfish: further evidence for opiate receptor heterogeneity.
    Nishimura S; Pasternak GW
    Brain Res; 1982 Sep; 248(1):192-5. PubMed ID: 6289993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [3H]Tyr-D-Ser-Gly-Phe-Leu-Thr: a specific probe for the delta-opiate receptor subtype in brain membranes.
    David M; Moisand C; Meunier JC; Morgat JL; Gacel G; Roques BP
    Eur J Pharmacol; 1982 Mar; 78(3):385-7. PubMed ID: 6279414
    [No Abstract]   [Full Text] [Related]  

  • 39. [Participation of agonists and antagonist of opiate receptors in the regulation of contractile activity of lymphatic microvessels of the rat mesentery].
    Khugaeva VK
    Biull Eksp Biol Med; 1990 Feb; 109(2):137-40. PubMed ID: 2159812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency.
    Cox BM; Chavkin C
    Mol Pharmacol; 1983 Jan; 23(1):36-43. PubMed ID: 6135144
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.